Skip to main content
Professional Technical IVT

chemorefractory

Describing cancer that shows no response to initial chemotherapy treatment, indicating primary drug resistance.

Full Definition

Chemorefractory refers to malignancies that demonstrate primary resistance to chemotherapy, failing to respond to first-line treatment regimens from the outset. This is distinguished from acquired resistance, where tumors initially respond to treatment but later develop resistance mechanisms. In gynecologic oncology, chemorefractory ovarian cancer carries a particularly poor prognosis and often requires alternative treatment approaches, including experimental therapies or clinical trials. The term is critical for treatment planning and prognostic discussions.

Usage

Usage note: Often confused with platinum-resistant, but chemorefractory is broader and applies to primary resistance to any chemotherapy regimen.

In Context

  • "The patient's chemorefractory ovarian cancer showed no reduction in CA-125 levels after three cycles of carboplatin and paclitaxel." — Clinical progress note
  • "Given the chemorefractory nature of the disease, enrollment in a clinical trial was recommended." — Multidisciplinary team meeting note

Also known as

chemoresistant treatment-refractory drug-resistant

Contrasted with

chemosensitive treatment-responsive

Don't confuse with

platinum-resistant platinum-refractory

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON